Assembly Biosciences Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 1,028.2% | -317.4% | -200.4% | -222.7% | -5.5% | -248.8% | -174.1% | -140.3% | 33.5% | -269.0% | -115.8% | -51.4% | |
| – | 1.2% | 0.6% | 0.4% | 0.5% | 0.4% | 0.4% | 0.3% | 0.3% | 0.1% | 0.3% | 0.1% | 0.1% | |
| – | 13.4% | 12.8% | 9.8% | 11.6% | 10.2% | 7.6% | 8.7% | 15.5% | 3.4% | 13.6% | 18.1% | 8.9% | |
| – | 1,165.7% | -158.2% | -72.8% | -87.2% | 127.6% | -160.1% | -75.5% | -66.9% | -20.5% | -165.3% | -101.3% | -57.5% | |
| – | 1.0% | 0.2% | 0.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.4% | 0.1% | 0.2% | 0.0% | 0.1% | |
| – | -1,251.6% | 298.6% | 59.8% | 357.8% | -91.0% | 69.9% | 176.5% | -1,467.0% | 50.0% | -65.5% | -688.5% | -313.3% | |
| – | 128.3% | 0.0% | 146.0% | 0.0% | 231.0% | 20.4% | 3.7% | 1,593.6% | 1.1% | 1.8% | 813.0% | 375.8% | |
| – | -95.1% | -18.9% | 5.4% | 135.0% | 134.5% | -158.5% | 6.2% | -13.6% | 84.6% | -332.8% | 8.7% | 11.1% | |
| – | 1,027.2% | -317.7% | -200.6% | -222.7% | -5.5% | -248.8% | -174.1% | -140.7% | 33.5% | -269.3% | -115.8% | -51.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.